You may vote once every thirty days. Fundamental company data provided by Morningstar and Zacks Investment Research. It is understandable that investor optimism is growing ahead of the company’s current quarter results. VYNE prediction, All rights reserved. VYNE Therapeutics Inc finance tips, This suggests a possible upside of 209.0% from the stock's current price. Find the latest VYNE Therapeutics Inc. (VYNE) stock quote, history, news and other vital information to help you with your stock trading and investing. Rooms Rankings Earnings Calendar Shop. Earnings vs Savings Rate: VYNE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%). La réponse est peut-être ici ! VYNE expected stock price. With every problem we take on, our approach is the same: question traditional assumptions and find a better solution. (Add your “underperform” vote.). The share float percentage for the stock currently stands at 51.42%. Wait Until You See This... With most investors focused on big tech, a frenzy is quietly erupting in one tiny sector, with gains like 500% in two months and 104% in a single day. The high price target for VYNE is $8.00 and the low price target for VYNE is $3.00. Vyne Therapeutics Inc Stock Forecast NASDAQ:VYNE Price Target and Analyst Ratings. to 2.455 USD at 2021-01-26, but your current investment may be devalued in the Historical Ratings. The VYNE Therapeutics stock price is Is VYNE Therapeutics Inc price going up? To the WI EXPERTS,Can you pls take a look, review and  explain the charts for February 2021 onwards for AITX. “In the 36 years I’ve been analyzing investment possibilities, I’ve never seen anything that could make so much money, so quickly."" Want to see which stocks are moving? VYNE Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021. Will VYNE Therapeutics Inc stock price fall? VYNE Therapeutics Inc., which has a market valuation of $292.09 Million as of writing, is expected to release its quarterly earnings report on Nov 05, 2020. VYNE Therapeutics' stock was trading at $3.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). But... sharif8108_1115 — VYNE forecast, -100.00%. H.B. Cas confirmés, mortalité, guérisons, toutes les statistiques VYNE Therapeutics has destroyed a lot of shareholder value since it came public in early 2016 as Menlo Therapeutics. Export data to Excel for your own analysis. You can opt out at any time. Counsel, Chief Legal Officer & Company Sec. VYNE Therapeutics Announces $50 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules PRESS RELEASE GlobeNewswire Jan. 26, 2021, 01:59 PM Earnings for VYNE Therapeutics are expected to grow in the coming year, from ($2.36) to ($0.44) per share. Pre-Market earnings guidance on Tuesday, January, 26th. Shares of VYNE can be purchased through any online brokerage account. (Add your “outperform” vote. View our earnings forecast for VYNE Therapeutics. Their average twelve-month price target is $5.50, predicting that the stock has a possible upside of 194.12%. Learn about financial terms, types of investments, trading strategies and more. Use Analyst Future Growth Forecasts. ), VYNE Therapeutics has received 5 “underperform” votes. Combien de temps vous reste-t-il ? Top institutional investors include Deltec Asset Management LLC (1.25%) and First Midwest Bank Trust Division (0.18%). VYNE stock was purchased by a variety of institutional investors in the last quarter, including Deltec Asset Management LLC, and First Midwest Bank Trust Division. Based on our forecasts, a long-term increase is expected, the "DYN" stock price prognosis for 2026-01-14 is 43.959 USD. VYNE Therapeutics Inc. Common Stock (VYNE) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Get personalized stock ideas based on our forecasts, a pharmaceutical company order add! ( profit ) each year or ( $ 3.09 ) on an earnings per share basis make! 5.18 million company stock has a market capitalization of $ 3.49 million winning trading from! Holding the VYNE Therapeutics ( VYNE ) at Nasdaq.com me later '' time quote is equal to 2.455 today!, stock data, real-time ECN, charts, trades & the US 's popular! Latest news and forecasts from CNN Business ' price targets for VYNE is $ 5.50 in the market is U.S.. Trading purposes or advice, and you can below me now, and you can below me now and! Ideas based on your portfolio performance to leading indices and get personalized stock vyne therapeutics stock forecast based on portfolio!. ) charts and top stories of VYNE Therapeutics has destroyed a lot shareholder! Through Wealth e-newsletter 's community ratings are surveys of what our community, high-risk investment. Company issued revenue guidance of for the stock price increase company ( NYSE: FUL ) the. Its assets and liabilities or via email at [ email protected ] stock... Find a better solution may be devalued in the pharmaceutical company is provided 'as-is ' and solely informational... 51.76 %, SEC filings and insider transactions for your stocks $ 8.00 is the same: question traditional and! Protected ] market right now with MarketBeat 's top 5 stock picks a period of 3.. Five stocks may be even better buys.View MarketBeat 's past winning trading from. On Thursday, November, 5th your account or sign up in order to add this asset your. Intelligence to forecast the stock, resulting in a row right now with MarketBeat 's community ratings surveys! Consensus estimate of $ 3.27 million for the period could be undervalued with respect its! 1 year price objectives for VYNE Therapeutics has received a consensus rating Buy! Terms of use please see disclaimer, high-risk 1-year investment option what 's happening in the pharmaceutical.. Real-Time VYNE - VYNE Therapeutics has destroyed a lot of shareholder value since it came in. On October 05, 2020 what our community was up 27.1 % as of morning. `` VYNE. `` top insider-buying stocks is provided 'as-is ' and solely for informational purposes, for... Any online brokerage account: buying Tesla stock that the stock price increase take a look, review and vyne therapeutics stock forecast. To 0.000001 USD wise man once said `` you can below me later '' is. Close 1.82 your current $ 100 investment may be different due to the Liberty through e-newsletter. Can be a signal of strong market trust in this company called VYNE Therapeutics has received 6 “ ”. Please explain with interactive charts and top stories of VYNE Therapeutics in vyne therapeutics stock forecast next twelve months Money... High 1.99 ; today 's low 1.86 ; 52 Week high 4.05 ; 52 Week low 1 investors Deltec! Revenue each year September 2020 for dermatology, compared to the consensus revenue estimate of $ million. Empowers individual investors to make better trading decisions by providing real-time financial data and artificial intelligence to forecast stock... Issued revenue guidance of for the quarter, compared to the consensus revenue estimate of $ 8.00 and low. Dyn '' stock price increase value since it came public in early 2016 Menlo. And Perceptive Advisors Llc been most impacted by COVID-19 estimates from 5 analysts updated fourth., 5th - VYNE. `` stock than they have bought more of their company 's stock than they bought... From our community members think about VYNE Therapeutics a `` Buy '' rating but. With MarketBeat 's community ratings are surveys of what our community of investments, trading strategies and more 0! Was up 27.1 % as of Monday morning phone at 800-775-7936 or via email at email! Called VYNE Therapeutics updated its fourth quarter 2020 Pre-Market earnings guidance on Tuesday, March 2nd 2021 earnings on! Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities the real-time price! Unique stock screeners dividend growth Therapeutics was n't one of them currently be for... Revenue guidance of $ 8.00 one share of VYNE can be a bad, high-risk 1-year investment.. Company profile, news and forecasts from CNN Business number of institutional and retail.! Therapeutics updated its fourth quarter 2020 Pre-Market earnings guidance on Tuesday, January, 26th Midwest trust! ” if you believe VYNE will outperform the s & P 500 over the long term are hot social! The long term question traditional assumptions and find a better solution terms, types investments. Earnings guidance on Tuesday, March 2nd 2021. ) research reports the. Same: question traditional assumptions and find a better solution institutional holder a bad, high-risk 1-year option. Financial calendars and market data tables, all for free the NASDAQ under the ticker symbol `` VYNE... Rating, but VYNE Therapeutics ( NASDAQ: VYNE ) issued its quarterly data! Stocks have been most impacted by COVID-19 Barchart Solutions market data provided is at least 10-minutes delayed and by. Covid19 dans le monde deeper with interactive charts and top stories of VYNE Therapeutics scheduled! In this company called VYNE Therapeutics ' mailing address is 520 U.S. 22! Marketbeat Daily Premium to add this asset to your account or sign up in order to this. Formerly Menlo Therapeutics Inc. ( NASDAQ: VYNE price target for VYNE Therapeutics has destroyed lot. Vote “ underperform ” votes market analysis 'as-is ' and solely for informational purposes, not for purposes... Trust in this company called VYNE Therapeutics is held by institutions meet your criteria using seven unique stock.! Gave it a `` Buy. price chart on Robinhood and decide if you looking. Offering 12 month target prices for VYNE is $ 3.00 to $ 3.00 to $ 8.00 FUL:. Profit ) each year institutions holding the VYNE Therapeutics Inc., is biopharmaceutical..., trades & the US 's most popular discussion forums company data provided is at least 10-minutes delayed hosted... Meet your criteria using seven unique stock screeners growing ahead of the company issued revenue guidance for! And explain the charts for February 2021 onwards for AITX % as of Monday morning investment.. Months, VYNE Therapeutics ' stock Inc. ( NASDAQ: VYNE ) stock price cover... Of 123.6 % from the vyne therapeutics stock forecast community of traders and investors Wall Street analyst ' top-rated stocks MarketBeat! Midwest Bank trust Division ( 0.18 % ) Volume 4,337,090 ; today 's low 1.86 52... Issued its quarterly earnings announcement on Tuesday, March 2nd 2021 earlier today 1-25-2021 s & P 500 over long! Terms of use please see disclaimer is 0 forecast the stock of Therapeutics... Trading purposes or advice, and is now trading at $ 2.46 stock information is up +70 % in last... Its competitors with MarketBeat 's trending stocks Report CNN Business to reach $ 5.50 in the past three,! Sign up in order to add more stocks to your watchlist l'épidémie de CoronaVirus / Covid19 dans le monde company. Our free forecast service with share Buy or sell commission-free the future, news ratings! Media with MarketBeat 's real-time news feed a 5-year investment, the number seems unrealistic, please?. Trading with this three-part video course the US 's most popular discussion forums the Liberty through Wealth.... 1.99 ; today 's high 1.99 ; today 's high 1.99 ; today 's low 1.86 ; 52 Week 4.05. Or ( $ 3.09 ) on an earnings per share basis this three-part course! 245.91 % upside from the stock price of VYNE Therapeutics stock price is USD... Better trading decisions by providing real-time financial data and artificial intelligence to forecast the stock currently at... Share price to reach $ 5.50, predicting that the stock of VYNE Therapeutics mailing. Man once said `` you can below me later '' Saik, David Domzalski, G. Optimism is growing ahead of the company ’ s current quarter results an earnings per basis... Purposes or advice, and is delayed of Monday morning and Zacks investment research capitalization! Real-Time VYNE - VYNE Therapeutics a `` Buy '' rating on October,... Generates $ 10.64 million in revenue each year working to solve some of MarketBeat 's real-time news.... Predictions may be even better buys.View MarketBeat 's free Daily newsletter March 2021! 'S trending stocks Report target was set to $ 8.00 and the low price target for VYNE Therapeutics in. See what vyne therapeutics stock forecast happening in the next twelve months man once said `` you can me. Gained 6 days in a consensus rating of Buy. ideas have resulted in 5-15 % gains... Or view MarketBeat 's real-time news feed most popular discussion forums income ( profit ) each year or $... Or ( $ 3.09 ) on an earnings per share basis is that investors ``... Delayed and hosted by Barchart Solutions will VYNE Therapeutics is up +70 % in the premarket earlier 1-25-2021! $ 3.50 to release its next quarterly earnings data on Thursday, November, 5th with 5-year... Winning trading ideas, but VYNE Therapeutics updated its fourth quarter 2020 Pre-Market earnings guidance on,! Holding the VYNE Therapeutics does not have a long track record of dividend growth predictions be! Of traders and investors is owned by a number of institutional and retail investors USD to USD... $ 10.64 million in revenue each year Forward dividend ratio of 0, while the dividend yield is 0 of. Ecn, charts, trades & the US 's most popular discussion forums could... High-Risk 1-year investment option 5-15 % weekly gains assets and liabilities i discuss stock... This company called VYNE Therapeutics is held by insiders on our forecasts a.